Market Snapshot

BSE Sensex: 73738.45 0.12%
BSE 500: 32589.5 0.31%
BSE 200: 10199.36 0.20%
BSE 100: 23435.85 0.14%
BSE Mid-Cap: 40584.17 0.52%
BSE Small-Cap: 46492.21 1.05%
BANKEX: 54319.13 0.18%
BSE IT Sector: 34487.08 0.42%
Nifty 50: 22368 0.14%
Nifty 500: 20652.65 0.38%
Nifty 200: 12478.35 0.30%
Nifty 100: 23116 0.16%
Nifty Midcap 100: 49614.85 1.06%
Nifty Small 100: 16687.15 1.23%
Nifty IT: 33714.55 0.52%
Nifty PSU Bank: 7150 0.05%

News:

Tata Consumer Q4 PAT slides 19...
NBCC rallies as new orders zoo...
Artson Engineering hits the ro...
Aarti Drugs Baddi facility get...
Mastek jumps on major Saudi co...

Concord Drugs Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

23 Apr 2024 | 03:59 PM

36.96

0.02 (0.05%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

26.92%

Return (1Y)

Beaten S&P BSE Sensex by 4.29%
More Volatile

3.64%

Standard Deviation (1Y)

Higher than S&P BSE Sensex by 3.01%
Not so consistent

5/12

Months

underperformed S&P BSE Sensex
AxisDirect View

No View

52 Week High-Low

News & Announcements

Concord Drugs reports consolidated net loss of Rs 0.24 crore in the December 2023 quarter
69 days ago

Concord Drugs reports consolidated net loss of Rs 0.24 crore in the December 2023 quarter

14 - Feb - 2024 12:00 AM | 69 days ago

Net loss of Concord Drugs reported to Rs 0.24 crore in the quarter ended December 2023 as against net profit of Rs 0.45 crore during the previous quarter ended December 2022. Sales declined 5.54% to Rs 12.78 crore in the quarter ended December 2023 as against Rs 13.53 crore during the previous quarter ended December 2022.
Particulars Quarter Ended
Dec. 2023 Dec. 2022 % Var.
Sales 12.78 13.53 -6
OPM % 4.93 10.64 -
PBDT 0.13 1.00 -87
PBT -0.26 0.62 PL
NP -0.24 0.45 PL
Powered by Capital Market - Live News
Concord Drugs to announce Quarterly Result
75 days ago

Concord Drugs to announce Quarterly Result

07 - Feb - 2024 12:00 AM | 75 days ago

Concord Drugs will hold a meeting of the Board of Directors of the Company on 13 February 2024.
Powered by Capital Market - Live News
Concord Drugs consolidated net profit rises 211.11% in the September 2023 quarter
160 days ago

Concord Drugs consolidated net profit rises 211.11% in the September 2023 quarter

15 - Nov - 2023 12:00 AM | 160 days ago

Net profit of Concord Drugs rose 211.11% to Rs 0.56 crore in the quarter ended September 2023 as against Rs 0.18 crore during the previous quarter ended September 2022. Sales declined 45.19% to Rs 7.52 crore in the quarter ended September 2023 as against Rs 13.72 crore during the previous quarter ended September 2022.
Particulars Quarter Ended
Sep. 2023 Sep. 2022 % Var.
Sales 7.52 13.72 -45
OPM % 21.41 8.67 -
PBDT 1.19 0.77 55
PBT 0.80 0.24 233
NP 0.56 0.18 211
Powered by Capital Market - Live News
Concord Drugs standalone net profit rises 194.44% in the September 2023 quarter
160 days ago

Concord Drugs standalone net profit rises 194.44% in the September 2023 quarter

15 - Nov - 2023 12:00 AM | 160 days ago

Net profit of Concord Drugs rose 194.44% to Rs 0.53 crore in the quarter ended September 2023 as against Rs 0.18 crore during the previous quarter ended September 2022. Sales declined 46.21% to Rs 7.38 crore in the quarter ended September 2023 as against Rs 13.72 crore during the previous quarter ended September 2022.
Particulars Quarter Ended
Sep. 2023 Sep. 2022 % Var.
Sales 7.38 13.72 -46
OPM % 20.73 8.67 -
PBDT 1.15 0.77 49
PBT 0.77 0.24 221
NP 0.53 0.18 194
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Promoter shareholding in Concord Drugs Ltd has increased by 13.08% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	12.78	13.53	-6
OPM %	4.93	10.64	-
PBDT	0.13	1.00	-87
PBT	-0.26	0.62	PL
NP	-0.24	0.45	PL

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	7.52	13.72	-45
OPM %	21.41	8.67	-
PBDT	1.19	0.77	55
PBT	0.80	0.24	233
NP	0.56	0.18	211

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	7.38	13.72	-46
OPM %	20.73	8.67	-
PBDT	1.15	0.77	49
PBT	0.77	0.24	221
NP	0.53	0.18	194

General Notifications

My Notifications

Research Notifications

Concord Drugs Ltd Share Price – BSE Pharmaceuticals, Small Cap

36.96 0.02 (0.05%)

News & Announcements

Price vs Volume

Stock Trivia

Concord Drugs Ltd Share Price – BSE
Pharmaceuticals, Small Cap

36.96

0.02 (0.05%)